> ## Content Index
> Fetch the complete content index at: https://aarr.org/llms.txt
> Use this file to discover other available public pages before exploring further.

# Chlorthalidone Blood Pressure Tablets Recalled Again: Check Your Bottle for Three Batch Numbers
- URL: https://aarr.org/chlorthalidone-25mg-recall-inventia-batch-numbers/
- Published: 2026-10-01T17:28:27.000Z
- Updated: 2026-10-01T17:28:27.000Z
- Description: Inventia Healthcare has recalled three batches of its chlorthalidone 25 mg blood pressure tablets this year because testing found they may not dissolve properly. Here are the batch numbers and codes to check on your bottle, and the FDA's guidance on whether to keep taking a recalled medicine.
- Author: AARR Staff
- Tags: News

## A Blood Pressure Pill Recalled Twice This Year

For anyone who takes chlorthalidone, the place to start is the label on the bottle. Inventia Healthcare Limited, a drug maker based in India, has recalled three batches of its 25 mg chlorthalidone tablets this year, once in June and again in September, because testing found the tablets may not dissolve properly. The two recalls together cover about 25,000 bottles. The Food and Drug Administration classified both as Class II, the middle of its three risk levels, where using the drug may cause temporary health consequences but a serious health issue is unlikely.

Chlorthalidone is a diuretic, or water pill, and it is prescribed for high blood pressure and for fluid retention. It reduces the amount of water and salt in the body by increasing urine flow, which helps lower blood pressure, according to the Mayo Clinic.

## The Three Recalled Batches

The June recall began on June 5, 2026, and the FDA classified it as Class II on June 22, 2026\. It covers 11,460 bottles in two sizes, which Rising Pharma Holdings, Inc., of East Brunswick, New Jersey, distributed nationwide. The FDA's [enforcement report entry for the June recall](https://www.accessdata.fda.gov/scripts/ires/?Event=99136) lists it as recall number D-0610-2026.

The September recall began on September 3, and the FDA classified it as Class II on September 17\. It covers 13,567 bottles of 100 tablets, distributed nationwide, and the FDA's [enforcement report entry for the September recall](https://www.accessdata.fda.gov/scripts/ires/?Event=99806) lists it as recall number D-0852-2026\. The FDA's record lists both recalls as ongoing. The three batches across the two recalls are:

- June recall, 100-tablet bottle: Batch RISA24001, National Drug Code (NDC) 64980-599-01, expiration date 04/2027
- June recall, 1000-tablet bottle: Batch RISB24002, NDC 64980-599-10, expiration date 04/2027
- September recall, 100-tablet bottle: Batch RISA24002, NDC 64980-599-01, expiration date 04/2027

## How to Tell Whether Your Bottle Is Affected

Any recalled medicine is checked the same way, the FDA says: compare the lot number on the label with the lot number in the recall notice, which for these tablets means the batch number. Read the batch number on the bottle against the three above, character by character, since RISA24001 and RISA24002 differ only in their last digit.

## What to Do If Your Bottle Matches

Consumers can generally continue taking a medicine under a Class II recall unless the company provides other instructions, according to the FDA. Stopping a medicine may in some instances be more harmful to a person's health than continuing to take a recalled one, the agency says on its page on [understanding drug recalls](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do). Anyone with questions or concerns about their medicine should talk to their doctor or pharmacist.

Companies may also advise consumers to return a recalled medication to the place of purchase, the FDA says, and most retailers have return and refund policies for recalled products. The FDA's record of these two recalls carries no phone number or website for patients.

## Why the Tablets Were Recalled

All three batches were recalled for the same reason, which the FDA gives as failed dissolution specifications. Tablets that fail dissolution testing may not dissolve, or break down, at the correct speed in the body, which can affect how the active ingredient is absorbed and how well the pill works.

## What a Class II Recall Means

Recalls fall into three classes by risk in the FDA's system. The most serious class covers recalls where there is a reasonable probability that using the drug will cause serious health consequences, and it generally involves removing the drug from the market. A Class II recall is one where using the drug may cause temporary health consequences but the probability of a serious health issue is remote. The third and least serious class is for drugs that are not likely to cause health consequences, which the FDA says could include minor labeling errors, defective packaging, or incorrect expiration dates.

## Keeping Up With Recalls

Not every recall is announced on FDA.gov or in the news, the FDA says, and public notice generally goes out when a widely distributed product or a serious health hazard is involved. Every recall the agency monitors is posted in its [enforcement report](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/enforcement-reports), and the report's [subscription service](https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=subscription.login) sends email notices of new and updated recalls, including notices by keyword such as the name of a medicine. Inventia's first notice of the September recall went out by letter, according to the FDA's record, and the agency's database shows no public announcement from the company.

For anyone on chlorthalidone, the three batch numbers above are the ones to check against the bottle. The FDA's page on understanding drug recalls carries its guidance in full, and a doctor or pharmacist can answer questions about the medicine itself.